Rockville-based Emergent BioSolutions is eliminating 300 jobs and will not fill 85 current job openings, as part of a broad restructuring that also includes closing manufacturing facilities, including one in the Maryland city. Emergent also reported quarterly revenue of $300 million, almost double revenue in the same quarter a year ago, and a $9 million profit, compared to steep losses in the first quarter of 2023.
Rockville-based Narcan maker Emergent is cutting hundreds of jobs
May 3, 2024